Background: Nonadherence to medication is a recognized problem and may be the most
challenging aspect of treatment. Methods: We performed a systematic review of factors that …

OBJECTIVE: Non-adherence is a major problem in the treatment of schizophrenia. Depot
antipsychotic drugs are thought to reduce relapse rates by improving adherence, but a …

Although non‐adherence is common across all branches of medicine, psychotic disorders
pose additional challenges that increase its risk. Despite the importance of non‐adherence …

Despite significant advances in treatment, stigma and discrimination toward persons with
mental illness and drug addiction have remained constant in past decades. Prior work …

Importance The risk of birth and neurodevelopmental complications with prenatal exposure
to antipsychotics is unclear. Objective To evaluate the association between prenatal …

Schizophrenia is a heterogeneous psychiatric disorder with a broad spectrum of clinical and
biological manifestations. Due to the lack of objective tests, the accurate diagnosis and …

Objectives: Atypical antipsychotic medications are a relatively new, increasingly prominent
component of the treatment armamentarium for bipolar disorder. Information on adherence …

Adherence to antipsychotic medication is critical for the treatment of patients with
schizophrenia. Impaired insight into illness is one of the principal drivers of medication …

Objective: To evaluate predictors of treatment discontinuation against medical advice and
poor medication adherence among first-episode patients treated with olanzapine …

It has remained unclear what factors relate to primary nonadherence to antipsychotic
treatment and whether specific agents and routes of administration differ in how patients …